Microcap Ledger Journey Medical Corp $DERM
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Scottsdale, AZ
- Fiscal year end
- December 31
What the company doesAI summary of filing
Journey Medical Corporation is a commercial-stage pharmaceutical company that sells and markets FDA-approved prescription drugs for dermatological conditions in the United States. The company has eight FDA-approved products in its portfolio, which it acquires through licensing or asset purchases and commercializes through its field sales organization. Journey generates revenue from product sales to specialty pharmacies, wholesalers, and distributors. The company is a controlled subsidiary of Fortress Biotech, Inc. [10-K 2026-03-26]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $34.47M | −$2.54M | $1.18M | $25.64M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $61.86M | −$11.43M | −$12.44M | $24.09M | [10-K 2026-03-26] |
| FY ended Dec 2024 | $56.13M | −$14.67M | −$9.13M | $20.30M | [10-K 2026-03-26] |
Capital structure and dilution
- Shelf registration
- S-3 filed 2026-01-15; declared effective 2026-01-21 [S-3 2026-01-15]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-01 | Toledano Miranda Jayne | grant | 50,000 | — | [4 2026-07-02] |
| 2026-07-01 | Smith Justin Adam | grant | 50,000 | — | [4 2026-07-02] |
| 2026-07-01 | Herskowitz Neil | grant | 50,000 | — | [4 2026-07-02] |
| 2026-06-25 | Toledano Miranda Jayne | grant | 10,000 | — | [4 2026-06-29] |
| 2026-06-25 | Smith Justin Adam | grant | 10,000 | — | [4 2026-06-26] |
| 2026-06-25 | Herskowitz Neil | grant | 10,000 | — | [4 2026-06-26] |
| 2026-06-25 | Pearce Michael Cooper | grant | 10,000 | — | [4 2026-06-26] |
| 2026-06-25 | Rosenwald Lindsay A Md | grant | 10,000 | — | [4 2026-06-26] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-08-12 | 8-K | Results of operations |
| 2026-07-31 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-26 | 8-K | Shareholder vote results |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Results of operations |
| 2026-04-30 | DEF 14A | Proxy statement |
| 2026-04-30 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-04-21 | 8-K | Other events |
| 2026-04-06 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $DERM
Email me when Journey Medical Corp files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.